Maxigen Biotech (Taiwan) Probability of Future Stock Price Finishing Over 44.60
| 1783 Stock | TWD 44.60 1.15 2.65% |
Maxigen |
Maxigen Biotech Target Price Odds to finish over 44.60
The tendency of Maxigen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 44.60 | 90 days | 44.60 | about 17.89 |
Based on a normal probability distribution, the odds of Maxigen Biotech to move above the current price in 90 days from now is about 17.89 (This Maxigen Biotech probability density function shows the probability of Maxigen Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Maxigen Biotech has a beta of -0.14. This suggests as returns on the benchmark increase, returns on holding Maxigen Biotech are expected to decrease at a much lower rate. During a bear market, however, Maxigen Biotech is likely to outperform the market. Additionally Maxigen Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Maxigen Biotech Price Density |
| Price |
Predictive Modules for Maxigen Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Maxigen Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Maxigen Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Maxigen Biotech is not an exception. The market had few large corrections towards the Maxigen Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Maxigen Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Maxigen Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.05 | |
β | Beta against Dow Jones | -0.14 | |
σ | Overall volatility | 1.37 | |
Ir | Information ratio | -0.15 |
Maxigen Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Maxigen Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Maxigen Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Maxigen Biotech generated a negative expected return over the last 90 days | |
| About 52.0% of the company shares are owned by insiders or employees |
Maxigen Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Maxigen Stock often depends not only on the future outlook of the current and potential Maxigen Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Maxigen Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 77 M |
Maxigen Biotech Technical Analysis
Maxigen Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Maxigen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Maxigen Biotech. In general, you should focus on analyzing Maxigen Stock price patterns and their correlations with different microeconomic environments and drivers.
Maxigen Biotech Predictive Forecast Models
Maxigen Biotech's time-series forecasting models is one of many Maxigen Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Maxigen Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Maxigen Biotech
Checking the ongoing alerts about Maxigen Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Maxigen Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Maxigen Biotech generated a negative expected return over the last 90 days | |
| About 52.0% of the company shares are owned by insiders or employees |
Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.